ThreadSky
About ThreadSky
Log In
technologyreview.com
•
101 days ago
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Comments
Log in
with your Bluesky account to leave a comment
[–]
kesmull.bsky.social
•
100 days ago
Too bad their research will likely be halted. GRRRRR.
0
reply
[–]
eseating.bsky.social
•
100 days ago
How many of those most at risk will be able to afford it?
0
reply
Posting Rules
Be respectful to others
No spam or self-promotion
Stay on topic
Follow Bluesky's terms of service
×
Reply
Post Reply
Comments